Your browser doesn't support javascript.
loading
Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections.
Lv, Huibin; Wu, Nicholas C; Tsang, Owen Tak-Yin; Yuan, Meng; Perera, Ranawaka A P M; Leung, Wai Shing; So, Ray T Y; Chan, Jacky Man Chun; Yip, Garrick K; Chik, Thomas Shiu Hong; Wang, Yiquan; Choi, Chris Yau Chung; Lin, Yihan; Ng, Wilson W; Zhao, Jincun; Poon, Leo L M; Peiris, J S Malik; Wilson, Ian A; Mok, Chris K P.
Afiliación
  • Lv H; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Wu NC; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Tsang OT; Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Hong Kong SAR, China.
  • Yuan M; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
  • Perera RAPM; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Leung WS; Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Hong Kong SAR, China.
  • So RTY; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Chan JMC; Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Hong Kong SAR, China.
  • Yip GK; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Chik TSH; Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Hong Kong SAR, China.
  • Wang Y; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Choi CYC; Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Hong Kong SAR, China.
  • Lin Y; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Ng WW; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Zhao J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Poon LLM; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Peiris JSM; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: malik@hku.hk.
  • Wilson IA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA; The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. Electronic address: wilson@scripps.edu.
  • Mok CKP; HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China. Electronic address: ch02mkp@hku.hk.
Cell Rep ; 31(9): 107725, 2020 06 02.
Article en En | MEDLINE | ID: mdl-33500101

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Reacciones Cruzadas / Síndrome Respiratorio Agudo Grave / Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo / SARS-CoV-2 / COVID-19 / Formación de Anticuerpos Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Reacciones Cruzadas / Síndrome Respiratorio Agudo Grave / Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo / SARS-CoV-2 / COVID-19 / Formación de Anticuerpos Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article